CRCA vs. SSO
CRCA (ProShares Ultra CRCL) and SSO (ProShares Ultra S&P500) are both Leveraged Equities funds from ProShares. CRCA is actively managed, while SSO is passively managed. At a 0.44 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 0.87%/yr for SSO.
Performance
CRCA vs. SSO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -68.22% return, which is significantly lower than SSO's 17.32% return.
CRCA
- 1D
- -9.58%
- 1M
- -40.68%
- 6M
- -70.42%
- YTD
- -68.22%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SSO
- 1D
- -1.53%
- 1M
- 1.94%
- 6M
- 13.10%
- YTD
- 17.32%
- 1Y
- 37.37%
- 3Y*
- 32.47%
- 5Y*
- 17.61%
- 10Y*
- 23.27%
CRCA vs. SSO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -68.22% | -84.67% |
SSO ProShares Ultra S&P500 | 17.32% | 14.26% |
Correlation
The correlation between CRCA and SSO is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. SSO — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
SSO
CRCA vs. SSO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and ProShares Ultra S&P500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | SSO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.27 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.07 | — |
| Martin ratioReturn relative to average drawdown | — | 8.51 | — |
Loading charts...
Drawdowns
CRCA vs. SSO - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.18%, which is greater than SSO's maximum drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for CRCA and SSO.
Loading charts...
Drawdown Indicators
| CRCA | SSO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.18% | -84.67% | -10.51% |
Max Drawdown (1Y)Largest decline over 1 year | — | -18.17% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -35.21% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -46.73% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -59.34% | — |
Current DrawdownCurrent decline from peak | -95.13% | -3.10% | -92.03% |
Average DrawdownAverage peak-to-trough decline | -72.99% | -19.49% | -53.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.40% | — |
Volatility
CRCA vs. SSO - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | SSO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 8.22% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 19.91% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 195.27% | 25.05% | +170.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 195.27% | 33.87% | +161.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 195.27% | 35.88% | +159.39% |
CRCA vs. SSO - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than SSO's 0.87% expense ratio.
Dividends
CRCA vs. SSO - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 6.93%, more than SSO's 0.67% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 6.93% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSO ProShares Ultra S&P500 | 0.67% | 0.68% | 0.85% | 0.18% | 0.50% | 0.18% | 0.20% | 0.50% | 0.75% | 0.39% | 0.51% | 0.63% |
Frequently Asked Questions
CRCA and SSO have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SSO is cheaper at 0.87% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SSO is cheaper with a 0.87% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 6.93%, compared with 0.67% for SSO.
Their fees differ too: 0.95% for CRCA and 0.87% for SSO.
Find the right allocation for CRCA and SSO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer